For research use only. Not for therapeutic Use.
Selexipag-d10 is a deuterated analog of Selexipag, designed for advanced pharmaceutical research. Containing ten deuterium atoms, it provides enhanced stability and precise analytical results in pharmacokinetic studies and drug metabolism research. This isotopically labeled compound is essential for tracing metabolic pathways and improving the accuracy of experimental outcomes. Ideal for researchers aiming to innovate in pulmonary arterial hypertension treatment, Selexipag-d10 is a crucial tool for high-quality, cutting-edge scientific investigations. Enhance your research with this reliable and effective compound.
Catalog Number | R036899 |
CAS Number | NA |
Synonyms | 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide-d10; 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide-d10;?ACT 293987-d10; NS 304-d10; Uptravi-d10; |
Molecular Formula | C₂₆H₂₂D₁₀N₄O₄S |
Purity | ≥95% |
Storage | Store at +4℃ |